Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with an aggressive type of lymphoma (a cancer of the lymphatic system), confirmed through a tissue sample test.
- People whose baseline PET/CT scan (a type of imaging scan) shows a moderate to high level of activity in the lymphoma areas.
- People who have no previous history of any other cancer.
- People who do not have serious problems with their heart, liver, or kidneys.
- People who are expected to live for at least 6 months and are able to attend all required follow-up appointments.
Who may not be able to join:
- People whose baseline PET/CT scan shows only low activity in the lymphoma areas.
- People whose lymphoma has already been fully removed by surgery, with no remaining areas available for the trial to assess.
- People who have an active or uncontrolled ongoing infection or inflammatory condition.
- People who have diabetes that is not well controlled.
- People whose medical records are incomplete, or who are unlikely to be able to complete all follow-up visits.
- People who are not willing to sign the consent form agreeing to take part in the trial.
- People who are unable to lie flat on their back for 30 minutes (as required for scanning procedures).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xuejuan Wang, M.D., Chinese Academy of Medical Sciences
Phone: 15621479631
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive Performance of FAPI PET/CT for Treatment Response or Disease Progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.